Georgia's Online Cancer Information Center

Find A Treatment Site

Northwest Georgia Oncology Centers - Douglasville

We’re committed to FIGHTING FOR YOU.   The cancer care and treatment experts at Northwest Georgia Oncology Centers, P.C. (NGOC) collaboratively work to provide patients with the most advanced cancer treatment options available in Georgia at nine cancer center locations.  NGOC oncologists are actively involved in cancer research through clinical trials, the treatment of difficult cancer cases and public policy to ensure people in Georgia have access to the best community-based cancer care.   NGOC is a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers.   For more information about NGOC cancer center locations and patient services, visit www.ngoc.com.

Treatment Sites in Georgia

Primary Location

6002 Professional Parkway
Suite 140
Douglasville, GA 30134
770-281-5101 (p)
www.ngoc.com

driving directions

Clinical Trials in Georgia

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Cancer Type: Breast Cancer, Unknown Primary

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Cancer Type: Lung Cancer

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Cancer Type: Breast Cancer, Unknown Primary

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Esophogeal Cancer, Stomach/ Gastric Cancer, Unknown Primary

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Cancer Type: Lung Cancer, Unknown Primary

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Cancer Type: Breast Cancer
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.